Skip to main content
. 2023 Mar 9;14(2):180–197. doi: 10.1177/19476035231154746

Table 4.

Overall Complication Rate per Treatment Option.

Treatment Option Studies
n
Lesions
n
Pooled Mean Age (Years) Pooled Mean Follow-Up (Months) Complication Rate
% (95% Confidence Interval)
Overall 178 6,962 35.5 46.3 5 (4-6)
Bone marrow stimulation therapies a 67 2,926 36.7 48.7 4 (3-6) a
Retrograde drilling b 14 289 32.6 39.2 5 (3-8) b
Fixation c 8 179 22.3 35.5 3 (1-8) c
Matrix-assisted bone marrow stimulation d 31 1,072 16.8 14.7 3 (2-4) d
Cartilage implantation e 22 479 32.8 47.5 5 (3-8) e
Osteo(chondral) autograft transplantation therapies f 61 1,639 34.7 54.2 8 (6-10) f
Osteo(chondral) allograft transplantation therapies g 15 288 43.1 30.8 8 (4-14) g
Metal implants h 3 80 41.7 54.4 15 (5-35) h
Other i 1 10 43.3 12 5 (0-45) i
a

Significantly different from osteo(chondral) autograft transplantation therapies (Q = 7.55, P = 0.0060) and metal implants (Q = 5.27, P = 0.0217).43,52,59,61 -63,66,81,92,93,109,113,117,121,123,125,131,135,141,143,146,149,150,153,158,164,165,167,168,171,173,176,177,179 -183,187,190,192,195 -200,202,204 -206

b

Significantly different from metal implants (Q = 3.86, P = 0.0493).11,42,53,56,59,116,118,137,170,177,194,196

c

Significantly different from metal implants (Q = 4.56, P = 0.0328).85,102,104,119,134,138,185,186

d

Significantly different from osteo(chondral) autograft transplantation therapies (Q = 16.86, P < 0.0001), osteo(chondral) allograft transplantation therapies (Q = 7.66, P = 0.0056), and metal implants (Q = 9.29, P = 0.0023).29,38,40,49,58,65,72,77,82,94,98,101,130,139,140,142,144,145,155,157,162,166,169,181,189,192,195,201,204

e

Significantly different from metal implants (Q = 3.95, P = 0.0468).14,41,45,46,51,64,76,78 -80,86,99,103,107,112,114,115,124,133,147,179

g

Multiple studies: 17,37,44,54,55,57,67,73,91,111,122,152,163,191,206.

h

Multiple studies: 27,28,69.

i

Study: 127 .